$TJX

TJX (TJX) Stock Declines While Market Improves: Some Information for Investors

TJX (TJX) ended the recent trading session at $159.26, demonstrating a -1.47% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.66%. Elsewhere, the Dow gained 1.19%, while the tech-heavy Nasdaq added 2.78%. Prior to today's trading, shares of the parent of T.J. Maxx, Marshalls and other stores had gained 6.79% outpaced the Retail-Wholesale sector's gain of 0.61% and the S&P 500's loss of 1.49%.

Original reporting
Published Jul 30, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TJX
Neutral
medium confidence
Mentioned
$TJX
Relevance
4/10
alphai data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

Traders are given consensus EPS and revenue targets plus the direction of estimate revisions and a Zacks Rank (#2 Buy), but there is no new earnings/guidance disclosure in the text.

02

Market read

This is a pre-earnings positioning note for TJX using consensus numbers and estimate-revision direction, not a new fundamental development.

03

What to watch

The piece does not discuss margin, inventory, guidance quality, or promotional intensity, which are typically the key drivers for discount retailers into earnings.

Relevance 4/10Novelty 3/10Timing: ahead of TJX’s upcoming earnings release

Background

TJX ended the session at $159.26, down 1.47%, and the article frames the next catalyst as the upcoming earnings release.

Company-level read

Ticker impact

$TJXNeutralMedium confidence
Context

Article notes TJX shares fell 1.47% and highlights upcoming earnings expectations (EPS $1.18, revenue $15.13B) and a Zacks Rank of #2.

Expected impact

Moderate volatility risk into the earnings date, with direction likely driven by whether results match or beat the $1.18 EPS and $15.13B revenue consensus.

Evidence & confidence

The text is a pre-earnings setup using consensus estimates and a small positive EPS estimate revision (+0.07% over a month), with no new company-specific disclosure beyond the market-implied expectations.

Market effects

Discount retail sentiment may be influenced by how TJX’s earnings compare with sector expectations, but no new sector catalyst is disclosed.

No specific regional linkage beyond US market tape context.

No direct global macro or supply-chain event is mentioned.

Counterpoint

Because the article is purely consensus-based and the stock already underperformed the S&P 500 on the day, the market may be underpricing downside risk if expectations are too optimistic.

Key entities

  • TJX

    Parent of T.J. Maxx and Marshalls; upcoming earnings expectations and estimate revisions are highlighted.

Related articles

$POWLMed

The Great Rotation: 5 Stocks Set to Win as Money Leaves Megacap Tech

The article says money is rotating out of megacap tech and into financials and energy, citing Nasdaq-100 down 3.28% over a month while the Russell 2000 rose 1.2%. It highlights JPMorgan’s Q2 2026 EPS $7.70 vs $5.80 and $57.35B revenue vs $51.30B, TJX’s Q1 FY27 EPS $1.19 vs $1.00, Devon’s Coterra merger and DVN dividend hike, and Robinhood’s Q1 2026 deposit and Gold subscriber growth.

$BURLMedAI 9/10

Burlington Beat Earnings Estimates, But Not Investor Expectations

Burlington Stores reported a quarter that cleared Wall Street estimates, but shares fell nearly 8% to around $300 before partially recovering. Management said higher oil prices and Middle East conflict affect its outlook, and it’s more cautious than in March due to higher gas prices and inflation risk. Analysts’ average 12-month target is about $357; consensus is Moderate Buy.

$NSPRMed

InspireMD, Inc. (NSPR): Results of Operations and Financial Condition

InspireMD, Inc. (NSPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 InspireMD Reports Second Quarter 2026 Financial Results - Company to host investor conference call today, August 17 th , at 8:30am EDT - Miami, FL — August 17, 2026 – InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), develope

$TSEMMed

Tower Semiconductor Misses Expectations but Guides to a Record $520M Quarter

Tower Semiconductor reported Q3 2026 EPS of $0.79, missing expectations and ending a five-quarter earnings beat streak. Revenue rose 16.3% year over year, supported by higher-value silicon photonics shipments and gross margin improvement. Management guided to a record $520M revenue quarter and said long-term customer advances rose to $145.4M. Japan expansion plans include METI-backed 300mm silicon photonics manufacturing.